demonstrating

Celldex Presents Data Demonstrating Profound Long Term Improvement in Angioedemain Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2025

June 14, 2025 10:48 ET  | Source: Celldex Therapeutics, Inc. 77% of patients (150 mg Q4W) treated with barzolvolimab who…

3 weeks ago

Jellybean Partners with Callaway to Reimagine Publishing for the Digital Age on Aptos

Jellybean™, Aptos, and Callaway launch Ely Callaway's digitally enhanced memoir "The Unconquerable Game." Each physical book features QR codes unlocking…

4 weeks ago

MeMed BV Surpasses 100,000 Patient Tests, Underscoring Adoption of Rapid Host-Response Diagnostics

— Milestone Achieved Through Growing Clinical Evidence Demonstrating Real-World Impact on Infection Management — — MeMed and Physicians Premier Celebrated…

4 weeks ago